Sunday, May 19, 2013 Last update: 5:34 AM
Company Tech News as it Breaks
Cannabis Science, Inc.
News articles for Cannabis Science, Inc.:
Wednesday, March 27, 2013
- Cannabis Science, Inc. Appoints Michael McGrath, MD, PhD, Professor, Departments of Laboratory Medicine, Pathology, and Medicine, UCSF, and Co-Founder of Biotechs Pathologica LLC and Neuraltus PharmacCOLORADO SPRINGS, Colo., March 27, 2013 /PRNewswire/ -- Cannabis Science, Inc. (NASDAQ OTC: CBIS) Cannabis Science announced today the appointment of Dr. Michael McGrath MD, PhD, Professor, Departments of Laboratory Medicine, Pathology, and Medicine at The University of California San Francisco (UCSF) to the Company's Scientific Advisory ... read more
Thursday, January 31, 2013
- CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as welCOLORADO SPRINGS, Colo., Jan. 31, 2013 /PRNewswire/ -- Cannabis Science, Inc. (NASD OTC: CBIS) announced today its Corporate Operational Guidance for 2013, highlighting a strategic action plan to "bring to market" innovative, cannabinoid-based, life-saving, anti-cancer drugs. The Company anticipates releasing a variety of cannabinoid-based treatments ... read more
Friday, December 14, 2012
- Cannabis Science, Inc., World AIDS Institute and Timothy Ray Brown Foundation Hold Special Event Tomorrow, December 15, in Las Vegas: 'All I Want For Christmas is a Cure'LAS VEGAS, Dec. 14, 2012 /PRNewswire/ -- Cannabis Science, Inc. (NASD OTC: CBIS) and non-profits World AIDS Institute and Timothy Ray Brown Foundation team up to raise awareness of the promise of ground-breaking Cannabinoid-based treatment of cancer, including HIV-related cancers such as Kaposi's Sarcoma, and ... read more
Tuesday, July 28, 2009
- Cannabis Science Receives FDA Industry Guidelines for Mapping Out Its Initial Drugs Offerings for FDA Submission and TestingSAN FRANCISCO, CA -- (Marketwire) -- 07/28/09 -- Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to report that the FDA has provided the Company with documentation to assist the Company to review and plan its initial applications to get its first drug into formal testing. Cannabis Science, Inc. President ... read more
Monday, July 27, 2009
- Cannabis Science to Apply to the FDA to Utilize Their Fast Track Procedures to Help Speed the Approval of Its Cannabinoid Medicines in Treatment of H1N1 Swine Flu as AP Report Predicts Swine Flu CouldSAN FRANCISCO, CA -- (Marketwire) -- 07/27/09 -- Cannabis Science, Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to report that it is moving as fast as possible to assist in the fight against the threat of a deadly influenza pandemic. In conjunction with its recent re-organization, the Company has begun ... read more